Page 97 - NobleCon20-Book-Project
P. 97
Intelligent Bio Solutions Inc.
SELECTED FINANCIAL ITEMS INBS
(in millions of USD)
CQ4 '23 CQ1 '24 CQ2 '24 CQ3 '24 LTM
Income Statement Key Items
Total Revenue 0.76 0.82 0.73 0.87 3.19
Gross Profit 0.20 0.18 0.82 0.35 1.54
Gross Margin 26% 22% 112% 40% 48%
EBIT (1.99) (2.95) (2.81) (2.73) (10.48)
EBIT Margin -261% -359% -386% -312% -329%
Net Income to Common Shareholders (1.98) (2.99) (2.80) (2.69) (10.45)
Net Margin -259% -363% -384% -309% -328%
Balance Sheet Key Items
Total Assets 8.83 17.04 13.78 11.73 11.73
Cash & Short Term Investments 1.12 9.40 6.30 3.99 3.99
% of Assets 13% 55% 46% 34% 34%
Current Assets -Total 2.94 11.52 8.53 6.48 6.48
% of Assets 33% 68% 62% 55% 55%
Total Liabilities 5.67 6.04 5.60 5.78 5.78
% of Assets 64% 35% 41% 49% 49%
Current Liabilities - Total 5.18 5.71 5.45 5.68 5.68
% of Assets 59% 33% 40% 48% 48%
Long Term Debt 0.23 0.15 NA NA NA
% of Assets 3% 1% NM NM NM
Total Equity 3.15 11.00 8.18 5.95 5.95
% of Assets 36% 65% 59% 51% 51%
Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (2.87) (2.45) (2.94) (2.39) (10.65)
Net Cash Flow - Investing (0.06) 0.00 (0.17) NA (0.22)
Net Cash Flow - Financing 3.79 10.77 0.01 0.04 14.60
Source: Capital IQ
PRICE / VOLUME
Source: Channelchek/QuoteMedia
Noble Capital Markets' Twentieth Annual Small & Microcap Investor Conference